{
    "title": "Amgen to buy Horizon Therapeutics in $26.4B deal",
    "url": "https://www.dailymail.co.uk/wires/ap/article-11528769/Amgen-buy-Horizon-Therapeutics-26-4B-deal.html",
    "date": "2022-12-12",
    "keywords": [
        "amgen",
        "horizon",
        "disease",
        "deal",
        "eye",
        "treatment",
        "year",
        "drugmaker",
        "drug",
        "cash",
        "acquisition",
        "ireland",
        "autoimmune",
        "tepezza",
        "half",
        "file",
        "company",
        "tax",
        "price",
        "announcement",
        "deeper",
        "developer",
        "monday",
        "share",
        "market",
        "chance",
        "portfolio",
        "raredisease",
        "october",
        "chemocentryx",
        "inflammatory",
        "bestseller",
        "bulging",
        "vision",
        "morning",
        "conference",
        "call",
        "version",
        "iv",
        "photo",
        "signage",
        "headquarters",
        "j",
        "terrill",
        "chairman",
        "ceo",
        "robert",
        "bradway",
        "platform",
        "life",
        "cycle",
        "krystexxa",
        "gout",
        "history",
        "pipeline",
        "potential",
        "midstage",
        "testing",
        "therapy",
        "myasthenia",
        "gravis",
        "latestage",
        "competition",
        "takeover",
        "sense",
        "mizuho",
        "analyst",
        "salim",
        "research",
        "note",
        "presence",
        "bill",
        "month",
        "sanofi",
        "johnson",
        "division",
        "place",
        "offer",
        "premium",
        "enterprise",
        "value",
        "stock",
        "november",
        "inc",
        "los",
        "california",
        "tom",
        "murphy",
        "twitter",
        "httpstwittercomthpmurphy"
    ],
    "category": [
        "wires",
        "ap"
    ]
}